Glaxosmithkline | Lånekapital



Loan Capital Endring Dato
AbbVie USD 60.34B 1.83B 2024-12
Amgen USD 56.55B 305M 2024-12
AstraZeneca USD 27.73B 2.29B 2024-12
Aurora Cannabis CAD 41.68M 542K 2024-12
Bausch Health Companies USD 21.05B 154M 2024-09
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Indivior 270M 2M 2024-09
J&J USD 30.65B 638M 2024-12
Merck USD 34.46B 520M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pacira USD 383.54M 2.35M 2024-12
Perrigo USD 3.58B 730.9M 2024-12
Pfizer USD 57.4B 597M 2024-12
Prestige Brands USD 996.05M 55.67M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 12.5B 1.84B 2024-06
Supernus Pharmaceuticals USD 0 0 2024-12
Takeda JPY 4.7T 277.59B 2024-12
Teva Pharmaceutical Industries USD 16B 398M 2024-12
Zoetis USD 5.22B 1.35B 2024-12



Glaxosmithkline Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.